The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression
Open accessAbstract
Oncogene-induced senescence causes hepatocytes to secrete cytokines, which induce their immune-mediated clearance to prevent tumor initiation, a process termed "senescence surveillance." However, senescent hepatocytes give rise to hepatocellular carcinomas (HCCs), if the senescence program is bypassed or if senescent cells are not cleared. Here, we show context-specific roles for CCR2+ myeloid cells in liver cancer. Senescence surveillance requires the recruitment and maturation of CCR2+ myeloid cells, and CCR2 ablation caused outgrowth of HCC. In contrast, HCC cells block the maturation of recruited myeloid precursors, which, through NK cell inhibition, promote growth of murine HCC and worsen the prognosis and survival of human HCC patients. Thus, while senescent hepatocyte-secreted chemokines suppress liver cancer initiation, they may accelerate the growth of fully established HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, a senescenceassociated gene signature was identified in the peritumoural area of hepatocellular carcinomas both in mice and humans, with the presence of this signature in the latter correlating with poor overall survival 90 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [90]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“By contrast, during cancer development associated with accumulation of senescent cells, SASP can recruit immature myeloid cells to promote tumorigenesis in a paracrine manner160,161.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [161]
The cited source says what the claim attributes to it.
In the citing paper
“Further, the SASP can recruit immature immune-suppressive myeloid cells to prostate and liver tumors (Di Mitri et al., 2014; Eggert et al., 2016) and stimulate tumorigenesis by driving angiogenesis and metastasis (Coppe ´ et al., 2010).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Eggert et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“In some instances, the SASP can also have immunosuppressive functions (Di Mitri et al. 2014; Eggert et al. 2016).”
From Senescence and the SASP: many therapeutic avenues (2020) · cites this paper as Eggert et al. 2016
The cited source says what the claim attributes to it.
In the citing paper
“For example, the SASP produced by preneoplastic hepatocytes recruits immature myeloid cells that inhibit NK cells, therefore contributing to HCC progression (Eggert et al. 2016).”
From Senescence and the SASP: many therapeutic avenues (2020) · cites this paper as Eggert et al. 2016
The cited source says what the claim attributes to it.
In the citing paper
“p16 INK4a , p21 and a variety of SASP factors were detected in patient- derived non- malignant tissue surrounding the tumour boundaries of hepatocellular carcinoma lesions 90 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [90]
The cited source says what the claim attributes to it.
In the citing paper
“Via secretion of CCL2, hepatocytes with Nras G12V - induced senescence attracted a subset of CCR2 + myeloid cells that engaged cytotoxic NK cells, eventually blocking tumour immune surveillance 90 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [90]
In the citing paper
“in later stages the tumor cells block the maturation of the accumulated iMC which eventually promote the growth of established hepatocellular carcinoma by inhibiting NK cell functions (Eggert et al., 2016).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Eggert et al., 2016
In the citing paper
“in the initial stages, SASP mediated recruitment of immature myeloid cells (iMC) which when differentiated into macrophages clear the pre-malignant senescence cells to prevent cancer initiation.”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Eggert et al., 2016
In the citing paper
“peritumoral tissue senescence has been associated with poor survival in patients with hepatocellular carcinoma [362].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [362]
In the citing paper
“There is convergent evidence that this occurs via the recruitment of myeloid-derived suppressor cells (MDSCs) chemoattracted by factors (e.g., IL-6, IL-8, and CCL2) secreted by senescent cells in murine models of HCC, 193 prostate, 194 and skin cancers.195”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [193]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Deshmane, S. L., Kremlev, S., Amini, S., & Sawaya, B. E. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0027 · Cited by 3,889
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Self-citationA complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278 · cited 5×
“These findings have important implic which are being evaluated for the treatment of various diseases pression in patients with advanced HCC but may fuel liver can Cancer neighboring tissue and immune cells (Acosta et al., 2013; Coppe et al., 2010; Kuilman et al., 2008).”
InfluentialSelf-citationOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 610
Li, J., Hu, K., He, D., Zhou, L., Wang, Z., & Tao, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.604131 · Cited by 22
Lin, W., Wang, X., Xu, Z., Wang, Z., Liu, T., Cao, Z., Feng, X., Gao, Y., & He, J. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02358-0 · Cited by 21
Self-citationSen, B., Aggarwal, S., Nath, R., Sehgal, R., Singh, R., Agrawal, K., Shashidhara, A. N., Rastogi, A., Bajpai, M., Pamecha, V., et al. (2022) · Medical Oncology · doi:10.1007/s12032-022-01732-w · Cited by 23
Ma, W., Li, Z.-H., Wu, Z., Liu, F., Wang, J.-K., Shi, Y., Jin, Y., & Li, F. (2023) · Neoplasia · doi:10.1016/j.neo.2023.100920 · Cited by 21
Xu, Z.-W., Yan, S., Wu, H., Chen, J., Zhang, Y., Li, Y., & Wei, W. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3267-z · Cited by 20
Hou, P.-P., Zheng, C.-M., Wu, S.-H., Liu, X.-X., Xiang, G., Cai, W., Chen, G., & Lou, Y. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-0832 · Cited by 19
Cellular senescence in tumor immune escape: Mechanisms, implications, and therapeutic potential
You, L., & Wu, Q. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104628 · Cited by 21
Hernández‐Mercado, E., Prieto‐Chávez, J. L., Arriaga‐Pizano, L., Hernández-Gutiérrez, S., Mendlovic, F., Königsberg, M., & López‐Díazguerrero, N. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910215 · Cited by 19
Cellular senescence associated immune responses in liver cancer
Greten, T. F., & Eggert, T. (2017) · Hepatic Oncology · doi:10.2217/hep-2017-0011 · Cited by 20
Self-citationXiao, M., Chen, W., Wang, C., Wu, Y., Zhu, S., Zeng, C., Cai, Y., Liu, C., & He, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.23622 · Cited by 21
Sharma, R., & Padwad, Y. S. (2019) · Nutrition · doi:10.1016/j.nut.2019.01.020 · Cited by 20
p16ink4a Positivity of Melanocytes in Non-Segmental Vitiligo
Lee, J. W., Kim, T. H., Park, T. J., & Kang, H. Y. (2020) · Diagnostics · doi:10.3390/diagnostics10110878 · Cited by 18
Senolysis Reduces Senescence in Veins and Cancer Cell Migration
Estepa‐Fernández, A., Alfonso, M., Morellá‐Aucejo, Á., García‐Fernández, A., Lérida‐Viso, A., Lozano‐Torres, B., Galiana, I., Soriano‐Teruel, P. M., Sancenón, F., Orzáez, M., et al. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100149 · Cited by 19
Morgan, M. P., Finnegan, E., & Das, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.10.002 · Cited by 19
Luo, Y., Liu, H., Fu, H. Y., Ding, G., & Teng, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.974377 · Cited by 18
Pang, X., Gao, S., Liu, T., Xu, F. X., Chang, F., Zhang, J. F., & Jiang, H. (2024) · Genomics · doi:10.1016/j.ygeno.2024.110800 · Cited by 20
Liu, Z., Zhang, Y., Li, D., & Fu, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116463 · Cited by 19
Li, D., Hu, M., Liu, Y., Du, P., Du, P., Li, C.-S., Cheng, L., Liu, P., Jiang, J., Su, L., et al. (2018) · Cell Discovery · doi:10.1038/s41421-017-0007-9 · Cited by 18
Liu, X., Liu, J., Xu, Y., Zhang, X., Wang, Y., Qing, L., Guo, W., Ding, J., & Meng, L. (2019) · International Journal of Cancer · doi:10.1002/ijc.32153 · Cited by 18
Therapy-induced senescence — an induced synthetic lethality in liver cancer?
Wolter, K., & Zender, L. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0262-3 · Cited by 18
Self-citationHan, Y., Micklem, G., & Kim, S. Y. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101849 · Cited by 16
Wu, S. K., Ariffin, J. K., Tay, S. C., & Picone, R. (2023) · Aging Cell · doi:10.1111/acel.13766 · Cited by 17
Banerjee, P., Gaddam, N., Pandita, T. K., & Chakraborty, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032877 · Cited by 17
Yang, Z., Gao, S., Wong, C. C., Liu, W., Chen, H., Shang, H., Wu, Z. Y., Xu, L., Zhang, X., Wong, N., et al. (2023) · The Journal of Pathology · doi:10.1002/path.6065 · Cited by 18
Decoding T cell senescence in cancer: Is revisiting required?
Magkouta, S., Markaki, E., Evangelou, K., Petty, R., Verginis, P., & Gorgoulis, V. G. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.11.003 · Cited by 17
Senescence and Cancer: In the Name of Immunosuppression
Llanos, S., & Serrano, M. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.015 · Cited by 17
Ho, T.-C., Wang, E.-Y., Yeh, K., Jeng, Y., Horng, J.-H., Wu, L., Chen, Y.-T., Huang, H., Hsu, C., Chen, P., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1918028117 · Cited by 17
Heinrich, S., Castven, D., Galle, P. R., & Marquardt, J. U. (2020) · Cancers · doi:10.3390/cancers12092495 · Cited by 18
Carpenter, V. J., Patel, B. B., Riccardo Autorino, B., Smith, S. C., Gewirtz, D. A., & Saleh, T. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188424 · Cited by 17
Mitochondria-driven elimination of cancer and senescent cells
Hubáčková, S., Novais, S. M., Davidová, E., Neužil, J., & Rohlena, J. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0256 · Cited by 19
Turano, P. S., Akbulut, E., Dewald, H. K., Vasilopoulos, T., Fitzgerald-Bocarsly, P., Herbig, U., & Martínez-Zamudio, R. I. (2026) · Cell Reports · doi:10.1016/j.celrep.2025.116795 · Cited by 16
Signaling pathways and targeted interventions for precancers
Yang, J., Wang, S., Li, X., Xu, H. E., Sun, T., Hu, T., Luo, J., & Zhou, H. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02342-4 · Cited by 16
Senescence in cancer: Hallmarks, paradoxes, and therapeutic promise
Hinterleitner, C., Goldberg, H. V., McHugh, D., Barthet, V. J. A., Filliol, A. A., & Lowe, S. W. (2026) · Cell · doi:10.1016/j.cell.2026.03.005 · Cited by 20
Huang, E., Ma, T., Zhou, J., Ma, N., Yang, W.-S., Liu, C., Hou, Z., Chen, S., Castria, T. B. D., Zeng, B., et al. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-3348 · Cited by 16
Huang, E., Ma, T., Zhou, J., Ma, N., Yang, W.-S., Liu, C., Hou, Z., Chen, S., Zong, Z., Zeng, B., et al. (2022) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-22-721 · Cited by 15
Chen, W., Zhang, W., Chen, M., Yang, C., Fang, T., Wang, H., Reid, L. M., & He, Z. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00714-4 · Cited by 17
Gao, C., Zhou, G., Cheng, M., Feng, L., Cao, P., & Zhou, G. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.956094 · Cited by 16
The microbiota and aging microenvironment in pancreatic cancer: Cell origin and fate
Chen, Z., Wang, Z., Du, Y., Shi, H., & Zhou, W. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188826 · Cited by 17
Cellular Senescence and Ageing
Reed, R., & Miwa, S. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-21410-3_7 · Cited by 16
Recent Advances in Senolysis for Age-Related Diseases
Aratani, S., & Nakanishi, M. (2023) · Physiology · doi:10.1152/physiol.00003.2023 · Cited by 16
Chen, M., Chen, W., Sun, S., Lu, Y., Wu, G., Xu, H., Yang, H., Li, C., He, W., Xu, M., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.08.034 · Cited by 16
The Regulation of Cellular Senescence in Cancer
Zhang, X., Gao, Y., Zhang, S., Wang, Y., Du, Y., Hao, S., & Ni, T. (2025) · Biomolecules · doi:10.3390/biom15030448 · Cited by 17
Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers
Hochnadel, I., Kossatz-Boehlert, U., Jedicke, N., Lenzen, H., Manns, M. P., & Yevsa, T. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1359362 · Cited by 16
Self-citationCai, T., Liang, Z., Chen, Z., Li, Y., Xiao, W., Liang, W., Xie, H., Liu, H., Zeng, Z., Yang, X., et al. (2025) · Autophagy · doi:10.1080/15548627.2025.2551680 · Cited by 15
Palazzo, A., Hernández‐Vargas, H., Goehrig, D., Médard, J., Vindrieux, D., Flaman, J., & Bernard, D. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215850 · Cited by 15
The Role of Aging and Senescence in Immune Checkpoint Inhibitor Response and Toxicity
Jain, S. S., Sojo, G. B., Sun, H., Friedland, B. N., McNamara, M. E., Schmidt, M. O., & Wellstein, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137013 · Cited by 17
Zhu, X.-Y., Liu, W., Hou, X., Zong, C., Yu, W., Shen, Z.-M., Qu, S., Tao, M., Xue, M., Zhou, D.-Y., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.12.008 · Cited by 15
Senescent macrophages in tumor: phenotypes, roles, and interventions
Shen, W., Huang, Y., Yang, X., Zhang, Y., Pan, Y., Xiao, Y., Wang, J., Wang, C., Mao, W., & Zhao, A. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08000-5 · Cited by 16
The Potent and Paradoxical Biology of Cellular Senescence in Cancer
Romesser, P. B., & Lowe, S. W. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061421-124434 · Cited by 15
Essential roles of B cell subsets in the progression of MASLD and HCC
Petriv, N., Suo, H., Hochnadel, I., Timrott, K., Bondarenko, N., Neubert, L., Reinhard, E., Jedicke, N., Kaufhold, P., Guzmán, C. A., et al. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101189 · Cited by 17
Self-citationZhou, H., Zheng, Z., Fan, C., & Zhou, Z. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.01.001 · Cited by 15
Stromal senescence contributes to age-related increases in cancer
Ye, J., Melam, A., & Stewart, S. A. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00840-9 · Cited by 16
Zhou, L., DeMarco, K. D., Murphy, K. C., Wu, Z., Li, J., Johnson, C., Liu, B., Giwa, H. K., Ma, B., Bhalerao, N., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-25-1212 · Cited by 18
Innate-like T lymphocytes in chronic liver disease
Papanastasatou, M., & Verykokakis, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1114605 · Cited by 12
Androgen signaling stabilizes genomes to counteract senescence by promoting XRCC4 transcription
Chen, Y., Zhen, Z., Chen, L., Wang, H., Wang, X., Sun, X., Song, Z., Wang, H., Lin, Y., Zhang, W., et al. (2023) · EMBO Reports · doi:10.15252/embr.202356984 · Cited by 12
Self-citationCellular Senescence in Liver Cancer: How Dying Cells Become “Zombie” Enemies
Gazzillo, A., Volponi, C., Soldani, C., Polidoro, M. A., Franceschini, B., Lleò, A., Bonavita, E., & Donadon, M. (2023) · Biomedicines · doi:10.3390/biomedicines12010026 · Cited by 14
Regulation of cell function and identity by cellular senescence
Huna, A., Massemin, A., Makulyte, G., Flaman, J., Martin, N., & Bernard, D. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202401112 · Cited by 13
Liver Macrophage Diversity in Health and Disease
Horn, P., & Tacke, F. (2024) · Results and problems in cell differentiation · doi:10.1007/978-3-031-65944-7_7 · Cited by 14
Immune senescence: A key player in cancer biology
Yang, Y., Fan, L., Li, M., & Wang, Z. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.12.001 · Cited by 15
Wu, J., Liu, X., Liu, Y., Su, W., & Zhuo, Y. (2025) · Bioengineering · doi:10.3390/bioengineering12060563 · Cited by 14
Zhang, Z., Zhu, Y., Xu, D., Li, T., Li, J., Xiao, Z.-T., Chen, M., Yang, X. L., Jia, H., Dong, Q., et al. (2021) · Europe PMC (PubMed Central) · Cited by 13
A novel prognostic model based on cellular senescence-related gene signature for bladder cancer
Luo, L., Li, F., Gong, B., Xi, P., & Xie, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.937951 · Cited by 13
Gao, B., Wang, Y., & Lu, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-28436-z · Cited by 14
MicroRNAs-associated with FOXO3 in cellular senescence and other stress responses
Khor, Y.-S., & Wong, P. (2023) · Biogerontology · doi:10.1007/s10522-023-10059-6 · Cited by 15
Cellular Origin of Hepatocellular Carcinoma
Schneller, D., & Angel, P. E. (2019) · Codon Publications eBooks · doi:10.15586/hepatocellularcarcinoma.2019.ch1 · Cited by 13
Cellular and Spatial Drivers of Unresolved Injury and Functional Decline in the Human KidneyPreprint
Lake, B. B., Ferreira, R. M., Hansen, J., Menon, R., Basta, J. M., Thiessen‐Philbrook, H., Reinert, S., Fallegger, R., Lagwankar, A. K., Chen, X., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.26.678707 · Cited by 18
Metabolic dysregulation of trained immunity in immune aging and the impact of dietary patterns
Grigorescu, A., Riza, A., Streață, I., & Netea, M. G. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00153.2025 · Cited by 16
Shi, H., Xiao, M., Li, Y., Liu, X., Na, J., Liang, C., Hua, J., Meng, Q., Wei, M., Wang, W., et al. (2025) · Theranostics · doi:10.7150/thno.112633 · Cited by 12
Eakin, A., McErlain, T., Burke, A., Eaton, A., Tipping, N., Allocca, G., & Branco, C. M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00799 · Cited by 12
Hsu, C., Mustafa, M. A., Kumar, A., Pramanik, A., Sharma, R., Mohammed, F., Jawad, I. A., Mohammed, I. J., Alshahrani, M. Y., Khalil, N. A. M. A., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155266 · Cited by 13
Xiong, F., Wang, B., Zhang, H., Zhang, G., Liu, Y., Liu, Y., & Wang, C. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113706 · Cited by 12
Chandra, A., Law, S. F., & Pignolo, R. J. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112059 · Cited by 13
Senotherapeutics: An emerging approach to the treatment of viral infectious diseases in the elderly
Li, Z., Tian, M., Wang, G., Cui, X., Ma, J., Liu, S., Shen, B., Liu, F., Wu, K., Xiao, X., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1098712 · Cited by 13
β-elemene promotes the senescence of glioma cells through regulating YAP-CDK6 signaling.
Yang, D., Xu, X., Wang, X., Feng, W., Shen, X., Zhang, J., Liu, H., Xie, C., Wu, Q., Miao, X., et al. (2021) · PubMed · Cited by 12
Self-citationCellular senescence in human liver under normal aging and cancer
Karpova, A., Li, X., Peng, C.-W., Gallant, K. L., Rapp, D. R., Alligood, D. M., Houston, A. J., Park, A., Targino da Costa, A. L. N., Chou, W.-H., et al. (2026) · Cell Genomics · doi:10.1016/j.xgen.2025.101133 · Cited by 13
Intracellular signaling modules linking DNA damage to secretome changes in senescent melanoma cells
Chavanet, A., Hill, K. R., Jiménez-Andrade, Y., Choo, M., White, K., & Park, J. M. (2020) · Melanoma Research · doi:10.1097/cmr.0000000000000671 · Cited by 11
Advances on Senescence-associated secretory phenotype regulated by circular RNAs in tumors
Qiu, Y., Zhang, S., Man, C., Gong, D., Xu, Y., Fan, Y., Wang, X., & Zhang, W. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102287 · Cited by 12
Self-citationXing, F., Lv, H., Xiang, W., Wang, L., Zong, Q., Lv, G., Liu, C., Feng, Q., Yang, W., & Yang, W. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217544 · Cited by 13
Suo, H., Hochnadel, I., Petriv, N., Franke, R., Schmidt, J., Ліманська, Н. В., Tugai, A., Jedicke, N., Bröenstrup, M., Manns, M. P., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.906468 · Cited by 11
Self-citationChemokine CCL5 immune subtypes of human liver cancer with prognostic significance
Xia, Y., Zhou, L., Yang, H., & Yu, D. C. W. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109372 · Cited by 11
Zhang, S., Zheng, Y., Li, X., Zhang, S., Hu, H., & Kuang, W. (2023) · Aging · doi:10.18632/aging.204658 · Cited by 13
Mechanisms of Senescence in Cancer: Positive and Negative Aspects of Cancer Cells Senescence
Zaczek, A., Kalenik, S., & Rodacka, A. (2023) · Cellular Physiology and Biochemistry · doi:10.33594/000000671 · Cited by 12
Okamura, K., Suzuki, T., & Nohara, K. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115259 · Cited by 11
The potential of targeting Sin3B and its associated complexes for cancer therapy
Cantor, D. J., & David, G. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1386655 · Cited by 11
Ziglari, T., Calistri, N. L., Finan, J. M., Derrick, D. S., Nakayasu, E. S., Burnet, M. C., Kyle, J. E., Hoare, M., Heiser, L. M., & Pucci, F. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-0875 · Cited by 11
Immunosenescence: Molecular Mechanisms, Diseases, and Therapeutic Innovations
Gong, N., Pan, X., Deng, Y., Che, J., Bao, J., Wang, M., Xu, C., Liu, X., & Shi, Y. (2025) · MedComm · doi:10.1002/mco2.70515 · Cited by 14
Cellular senescence in cancer: Friend or fraud?
Chen, Q., Liu, J., Wu, J., Xiang, X., Zhou, X., Mi, J., Wei, J., Zou, X., & Wu, A. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101363 · Cited by 15
Shen, X., Wang, M., Chen, W., Xu, Y., Zhou, Q., Zhu, T., Wang, G., Cai, S., Han, Y., Xu, C., et al. (2023) · Aging · doi:10.18632/aging.204524 · Cited by 10
Targeting treatment resistance in cervical cancer: A new avenue for senolytic therapies
Meyer, M., Fourie, C., der Merwe, F. H. V., Botha, M. H., & Engelbrecht, A. (2024) · Advances in Medical Sciences · doi:10.1016/j.advms.2024.11.001 · Cited by 10
Lai, W., Feng, Q., Wen, L., Xiao, C., Wang, J., Zhu, Y. M., Mao, L., Zhu, Y., He, J., Li, Y., et al. (2025) · Aging Cell · doi:10.1111/acel.70082 · Cited by 14
Nanomaterials intervene in cell senescence to reinforce cancer therapy
Sun, S., Yang, N., Nie, J., Yang, Z., Pei, Z., Ding, R., & Cheng, L. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217012 · Cited by 10
Liang, C., Zhang, G., Guo, L., Ding, X., Yang, H., Zhang, H., Zhang, Z., & Hou, L. (2024) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2024.100888 · Cited by 10
Bai, Z., Zhou, Y., Ye, X., Li, Y., Peng, Y., Guan, Q., Zhang, W., & Ma, L. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119174 · Cited by 9
Cotarelo, C., Schad, A., Schmidt, M., Hönig, A., Sleeman, J. P., & Thaler, S. (2023) · Cancers · doi:10.3390/cancers15061860 · Cited by 10
Wang, Z., Chen, C., Ai, J., Gao, Y., Wang, L., Xia, S., Jia, Y., & Qin, Y. (2025) · MedComm · doi:10.1002/mco2.70048 · Cited by 12
Pan, Q., Ye, Z., Ye, Z., Zhang, H., Wang, J., Yi, G., Li, Z., Xu, R., Wang, L., Wu, Z., et al. (2025) · BMEMat · doi:10.1002/bmm2.12137 · Cited by 9
Myeloid cell path to malignancy: insights into liver cancer
Ramirez, C. F. A., & Akkari, L. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.02.006 · Cited by 11
Liu, W., Fan, B., Fang, T., Li, H., Zhang, J., Liu, B., & Liu, Z. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.08.010 · Cited by 10
Redefining senescence through hepatocyte fate changes in liver diseases
Umbaugh, D. S., Diehl, A. M., & Du, K. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.08.003 · Cited by 10
Vanderborght, B., Muynck, K. D., Gijbels, E., Lefere, S., Scott, C. L., Guilliams, M., Beschin, A., Vinken, M., Verhelst, X., Geerts, A. M., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34505 · Cited by 9
Metadata
- Authors
- Eggert, T., Wolter, K., Ji, J., Ma, C., Yevsa, T., Klotz, S., Medina-Echeverz, J., Longerich, T., Forgues, M., Reisinger, F., Heikenwalder, M., Wang, X. W., Zender, L., & Greten, T. F.
- Affiliations
- National Institutes of Health (US)
- University of Tübingen (DE)
- Universitätsklinikum Aachen (DE)
- German Cancer Research Center (DE)
- Corresponding author
- Zender, Lars
- Greten, Tim F.
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 30
- Issue
- 4
- Pages
- 533-547
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC7789819
- OpenAlex
- W2530995434
- Semantic Scholar
- 45e8e4d91cc1db28efeb781d9d19abda9935ae32
- Cited by
- 609
- References
- 40
- Citations by year
- 2026: 50 · 2025: 68 · 2024: 86 · 2023: 71 · 2022: 76 · 2021: 75 · 2020: 66 · 2019: 41 · 2018: 44 · 2017: 31 · 2016: 1
- FWCI
- 23.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Site cant be reached (submittedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- DFG (FOR2314, SFB685)
- Gottfried Wilhelm Leibniz Program
- European Research Council
- German Ministry for Education and Research
- German Universities Excellence Initiative
- German Center for Translational Cancer Research
- German-Israeli Cooperation in Cancer Research
- Stiftung Experimentelle Biomedizin
- Pre-clinical Comprehensive Center
- Helmholtz foundation
- NIH
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- oncogene-induced senescence, hepatocellular carcinoma, CCR2, myeloid cell recruitment, chemokines, NK cell inhibition, tumor progression, tumor initiation
- MeSH terms
- Animals, Female, Carcinoma, Hepatocellular, Humans, Immunologic Surveillance, Liver Neoplasms, Mice, Inbred BALB C, Mice, Inbred C57BL, Cellular Senescence, Mice, Knockout, Disease Progression, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
